Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04533061 · ClinicalTrials.gov registry record
Influenza Vaccine in Lung Transplant Patients - T Cells
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 24
- Enrollment target
NCT04533061: Completed study, sponsored by University of Wisconsin, Madison.
NCT04533061 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04533061 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This trial is designed to investigate the hypothesis that there is no difference in T Cell response to the influenza vaccine between lung transplant patients and healthy controls.
Primary Outcome
Blood was drawn prior to and 2-4 weeks after immunization and used to measure antibody responses by hemagglutination inhibition assay
Interventions
- DRUG Influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-07 |
What the finished NCT04533061 record still lists
NCT04533061 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Influenza vaccine is the first listed.
NCT04533061 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04533061 about?
NCT04533061 is a clinical study titled "Influenza Vaccine in Lung Transplant Patients - T Cells". This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This trial is designed to investigate the hypothesis that there is no ...
What is the current status of trial NCT04533061?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2004-12. Estimated completion is 2009-07.
What interventions are being tested in trial NCT04533061?
The interventions under investigation include: Influenza vaccine (DRUG).
Who is sponsoring clinical trial NCT04533061?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia